1. Academic Validation
  2. Structural insights into small-molecule agonist recognition and activation of complement receptor C3aR

Structural insights into small-molecule agonist recognition and activation of complement receptor C3aR

  • EMBO J. 2025 May;44(10):2803-2826. doi: 10.1038/s44318-025-00429-w.
Jinuk Kim # 1 2 Saebom Ko # 1 Chulwon Choi 1 Jungnam Bae 1 Hyeonsung Byeon 3 Chaok Seok 3 Hee-Jung Choi 4
Affiliations

Affiliations

  • 1 Department of Biological Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
  • 2 Division of Biological Science and Technology, Yonsei University, Wonju, 26493, Republic of Korea.
  • 3 Department of Chemistry, Seoul National University, Seoul, 08826, Republic of Korea.
  • 4 Department of Biological Sciences, Seoul National University, Seoul, 08826, Republic of Korea. choihj@snu.ac.kr.
  • # Contributed equally.
Abstract

The Complement System plays crucial roles in innate immunity and inflammatory responses. The anaphylatoxin C3a mediates pro-inflammatory and chemotactic functions through the G protein-coupled receptor C3aR. While the active structure of the C3a-C3aR-Gi complex has been determined, the inactive conformation and activation mechanism of C3aR remain elusive. Here we report the cryo-EM structure of ligand-free, G protein-free C3aR, providing insights into its inactive conformation. In addition, we determine the structures of C3aR in complex with the synthetic small-molecule agonist JR14a in two distinct conformational states: a G protein-free intermediate, and a fully active Gi-bound state. The structure of the active JR14a-bound C3aR reveals that JR14a engages in highly conserved interactions with C3aR, similar to the binding of the C-terminal pentapeptide of C3a, along with JR14a-specific interactions. Structural comparison of C3aR in the apo, intermediate, and fully active states provides novel insights into the conformational landscape and activation mechanism of C3aR and defines a molecular basis explaining its high basal activity. Our results may aid in the rational design of therapeutics targeting complement-related inflammatory disorders.

Keywords

Activation Mechanism; C3a Receptor; G Protein Signaling; JR14a; cryo-EM Structure.

Figures
Products